Nektar Therapeutics
NKTR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000906709
In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Nektar Therapeutics changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 139 | 2 | 127 | −10 |
| Shares | 143.2M | 21.6K | 119.2M | −24.0M (−16.7%) |
| Value | $85.3M | $12.9K | $67.3M | −$17.9M (−21.0%) |
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Nektar Therapeutics at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 128,166 | $72.4K | 0.00% |
| Mackenzie Financial Corp | 75,034 | $42.4K | 0.00% |
| XTX Topco Ltd | 73,212 | $41.4K | 0.01% |
| US Asset Management LLC | 38,071 | $22.0K | 0.02% |
| Scientech Research LLC | 30,224 | $17.1K | 0.02% |
| Two Sigma Securities, LLC | 21,535 | $12.2K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 19,400 | $11.0K | 0.00% |
| Confluence Wealth Services, Inc. | 11,685 | $6.60K | 0.00% |
| Choate Investment Advisors | 11,580 | $6.54K | 0.00% |
| Allworth Financial LP | 9,900 | $5.59K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 3,300 | $1.86K | 0.00% |
| WealthCollab, LLC | 300 | $170 | 0.00% |
| The PNC Financial Services Group, Inc. | 100 | $57 | 0.00% |
| Advisory Services Network, LLC | 3 | $2 | 0.00% |
| Ronald Blue Trust, Inc. | 362 | $0 | 0.00% |
Sold out (25)
Institutions that held Nektar Therapeutics at the end of Q3 2023 and filed for Q4 2023 without it.
Not filed for Q4 2023 yet (2)
Institutions that held Nektar Therapeutics at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Ropes Wealth Advisors LLC | 11,580 | $6.90K |
| Hall Private Wealth Advisors | 10,000 | $5.96K |